Page last updated: 2024-10-24

carbazilquinone and Cancer of Gallbladder

carbazilquinone has been researched along with Cancer of Gallbladder in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Research Excerpts

ExcerptRelevanceReference
"Four patients with gallbladder cancer and two with bile duct cancer were treated with mitomycin C, carboquone, 5-fluorouracil and OK-432 (MQF-OK therapy) plus tegafur (FT) or UFT."3.67[MQF-FT and MQF-UFT in gallbladder and bile duct cancer]. ( Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakata, Y1
Fukushi, G1
Tsushima, K1
Suzuki, H1
Kimura, T1
Kimura, M1
Tamura, Y1
Kishibe, T1
Saitoh, S1
Itoh, T1

Other Studies

1 other study available for carbazilquinone and Cancer of Gallbladder

ArticleYear
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:9

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Car

1988